Related Experiment Video
Updated: Apr 30, 2026

Transition of Farm Pigs to Research Pigs using a Designated Checklist followed by Initiation of Clicker Training - a Refinement Initiative
Published on: August 21, 2021
Innovation in animal health under Regulation (EU) 2019/6: Review and recommendations
Klaus Hellmann1, Helen Jukes1, Matthias Hofer2
1Klifovet GmbH, Munich, Germany.
Abstract:
This report synthesizes the outcomes of an interdisciplinary conference held in Munich in 2025 to evaluate the impact of the EU Veterinary Medicinal Products Regulation (EU) 2019/6 (1) and associated legislation on innovation in the animal health sector. It highlights the regulatory, scientific, and commercial challenges faced by stakeholders and proposes strategic actions to foster innovation, particularly in the context of limited markets, novel therapies, and sustainability. The report draws on expert presentations and panel discussions, offering a comprehensive overview of the current landscape and a call for regulatory and procedural adaptations to support the development and availability of veterinary medicinal products (VMPs).
Related Concept Videos
Drug Regulation
Drug Products: Biologics, Biosimilars and Interchangeables
Clinical Significance of Antibiotic Resistance
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Microorganisms in Medicine and Therapeutics
Drug Control Governance: Regulatory Bodies and Their Impact

